aTYR PHARMA INC 10-Q filing
Filed 2025-08-07 · Report date 2025-06-30 · 2025
Filing metadata
- Accession number
- 0001339970-25-000009
- Form type
- 10-Q
- CIK
- 0001339970
- Primary document
- https://www.sec.gov/Archives/edgar/data/1339970/000133997025000009/atyr-20250630.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for aTYR PHARMA INC.
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $0 | - | - |
| Operating Income | $-36.1M | - | - |
| Net Income | $-34.4M | - | - |
| Eps Basic | -0.39 | - | - |
| Eps Diluted | -0.39 | - | - |
| Cash And Equivalents | $17.2M | - | - |
| Total Assets | $101.5M | - | - |
| Shareholders Equity | $74.8M | - | - |
| Operating Cash Flow | $-29.3M | - | - |
| Capital Expenditures | $9,000 | - | - |